K. Pavelka

EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2007)

Zhang, W., Doherty, M., Leeb, B.F., Alekseeva, L., Arden, N.K., Bijlsma, J.W., ...

OBJECTIVES: To develop evidence based recommendations for the management of hand osteoarthritis (OA). METHODS: The multidisciplinary guideline development group comprised 16 rheumatologists, one...

Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003 (2006)

Hanova, P., Pavelka, K., Dostal, C., Holcatova, I., Pikhart, H.

Objective: To estimate the annual incidence and prevalence of rheumatoid arthritis (RA), juvenile arthritis (JIA) and gout in a population based study in two regions of the Czech Republic with total...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison (2006)

Combe, B., Codreanu, C., Fiocco, U., Gaubitz, M., GEUSENS, Piet, Kvien, T., ...

To compare the efficacy and safety of etanercept and sulfasalazine, alone and in combination, in patients with active rheumatoid arthritis despite sulfasalazine treatment.Methods: A double-blind,...

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) (2005)

Zhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., ...

Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H., Rozman, B., Genovese, M., ...

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis (2005)

Holten, J. Van, Pavelka, K., Vencovsky, J., Stahl, H-D., Rozman, B., Genovese, M., ...

Pentosidine in serum and synovial fluid in patients with knee osteoarthritis and its potential role of prediction of osteoarthritis progression (2003)

Pavelka, K, Senolt, L, Vilim, V, Spacek, P, Braun, M, Forejtova, S

No abstract available.

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) (2003)

Jordan, K.M., Arden, N.K., Doherty, M., Bannwarth, B., Bijlsma, J.W., Dieppe, P., ...

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach. Methods: The literature search and guidelines...

Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients (2003)

Codreanu, C, Combe, B, Fiocco, U, Gaubitz, M, Kvien, T, Pavelka, K, ...

Centrul Metodol Reumatol, Bucharest, Romania. Hop Lapeyronie, Serv ImmunoRhumatol, Montpellier, France. Polyclin Univ, Cattedra Reumatol, Azienda Clin Osped Padova, Padua, Italy. Polyclin Univ, Div...

Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients (2003)

Codreanu, C, Combe, B, Fiocco, U, Gaubitz, M, Kvien, T, Pavelka, K, ...

Centrul Metodol Reumatol, Bucharest, Romania. Hop Lapeyronie, Serv ImmunoRhumatol, Montpellier, France. Polyclin Univ, Cattedra Reumatol, Azienda Clin Osped Padova, Padua, Italy. Polyclin Univ, Div...

Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis. (2002)

Combe, BG, Codreanu, C, Fiocco, U, Gaubitz, M, Kvien, TK, Pavelka, K, ...

H Lapeyron, Montpellier, France. C Metod Reumat, Bucharest, Romania. Clin Osp, Padua, Italy. Univ Munster, D-4400 Munster, Germany. Limburgs Univ Ctr, Diepenbeek, Belgium. Dia Syk, Oslo, Norway. Inst...

Double-blind comparison of etanercept and sulfasalazine,alone and combined in patients with active rheumatoid arthritis. (2002)

Combe, BG, Codreanu, C, Fiocco, U, Gaubitz, M, Kvien, TK, Pavelka, K, ...

H Lapeyron, Montpellier, France. C Metod Reumat, Bucharest, Romania. Clin Osp, Padua, Italy. Univ Munster, D-4400 Munster, Germany. Limburgs Univ Ctr, Diepenbeek, Belgium. Dia Syk, Oslo, Norway. Inst...

Hydroxychloroquine sulphate in the treatment of rheumatoid arthritis: a double blind comparison of two dose regimens.

Pavelka, K, Sen, K P, Pelísková, Z, Vácha, J, Trnavský, K

A controlled, double blind, parallel group, long term study of hydroxychloroquine sulphate in the treatment of rheumatoid arthritis, comparing daily doses of 200 mg and 400 mg, is described. The...

Histological study of effects of colloidal 90 yttrium on knee joint tissues of rabbits.

Pavelka, K, Meier-Ruge, W, Müller, W, Fridrich, R

The administration of 0-2-0-4 mCi 90 yttrium (90Y) into a normal rabbit knee joint fails to induce medical synovectomy and results in the proliferation of the synovialis. The synovial mesothelium...

Effect of yttrium 90 on experimental allergic arthritis in rabbits.

Meier-Ruge, W, Müller, W, Pavelka, K

Seventeen rabbits were immunized with complete Freund's adjuvant and bovine serum albumin by the method of Dumonde and Glynn (1962), as modified by Cooke and Jasin (1972). Fifteen weeks after...

EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Pendleton, A, Arden, N, Dougados, M, Doherty, M, Bannwarth, B, Bijlsma, J, ...

BACKGROUND—Osteoarthritis (OA) is the most common joint disease encountered throughout Europe. A task force for the EULAR Standing Committee for Clinical Trials met in 1998 to determine the...

EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)

Jordan, K, Arden, N, Doherty, M, Bannwarth, B, Bijlsma, J, Dieppe, P, ...

Objectives: To update the EULAR recommendations for management of knee osteoarthritis (OA) by an evidence based medicine and expert opinion approach.

A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis

Van Holten, J, Pavelka, K, Vencovsky, J, Stahl, H, Rozman, B, Genovese, M, ...

Objective: To assess the efficacy of interferon beta (IFNß) in combination with methotrexate in treatment of patients with rheumatoid arthritis.

EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

Zhang, W, Doherty, M, Arden, N, Bannwarth, B, Bijlsma, J, Gunther, K, ...

Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA).

Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein

Senolt, L, Braun, M, Olejarova, M, Forejtova, S, Gatterova, J, Pavelka, K

Background: Pentosidine, an advanced glycation end product, increasingly accumulates in articular cartilage with age, and contributes to the pathogenesis of osteoarthritis (OA). Increased...

Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists

Gossec, L, Dougados, M, Phillips, C, Hammoudeh, M, De Vlam, K, Pavelka, K, ...